Terms: = Pancreatic cancer AND MUTYH, MYH, 4595, ENSG00000132781, hMYH, MGC4416, MYHbeta AND Treatment
5 results:
1. Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan.
Cheng SM; Su YY; Chiang NJ; Wang CJ; Chao YJ; Huang CJ; Tsai HJ; Chen SH; Chang CY; Tsai CR; Li YJ; Yen CJ; Chuang SC; Chang JS; Shan YS; Hwang DY; Chen LT
J Biomed Sci; 2024 Feb; 31(1):21. PubMed ID: 38350919
[TBL] [Abstract] [Full Text] [Related]
2. Favorable response to immunotherapy in a pancreatic neuroendocrine tumor with temozolomide-induced high tumor mutational burden.
Cao Y; Ma Y; Yu J; Sun Y; Sun T; Shao Y; Li J; Shen L; Lu M
Cancer Commun (Lond); 2020 Dec; 40(12):746-751. PubMed ID: 33230973
[TBL] [Abstract] [Full Text] [Related]
3. A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants.
Earl J; Galindo-Pumariño C; Encinas J; Barreto E; Castillo ME; Pachón V; Ferreiro R; Rodríguez-Garrote M; González-Martínez S; Ramon Y Cajal T; Diaz LR; Chirivella-Gonzalez I; Rodriguez M; de Castro EM; García-Seisdedos D; Muñoz G; Rosa JMR; Marquez M; Malats N; Carrato A
EBioMedicine; 2020 Mar; 53():102675. PubMed ID: 32113160
[TBL] [Abstract] [Full Text] [Related]
4. Characterization of novel genetic alterations in salivary gland secretory carcinoma.
Na K; Hernandez-Prera JC; Lim JY; Woo HY; Yoon SO
Mod Pathol; 2020 Apr; 33(4):541-550. PubMed ID: 31822803
[TBL] [Abstract] [Full Text] [Related]
5. Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes.
Wong W; Lowery MA; Berger MF; Kemel Y; Taylor B; Zehir A; Srinivasan P; Bandlamudi C; Chou J; Capanu M; Varghese A; Yu KH; Iacobuzio-Donahue CA; Shia J; Klimstra DS; Jarnagin WR; Stadler ZK; O'Reilly EM
Cancer; 2019 May; 125(9):1441-1448. PubMed ID: 30620386
[TBL] [Abstract] [Full Text] [Related]
